Democrats Remain Jealous Of Britain’s Healthcare Catastrophe

Forbes | Sally C. Pipes
July 6, 2020

Of course, “elective” can be a subjective term. Many American patients are putting off treatment for cancer, cardiovascular diseases, and other chronic conditions in order to avoid potential exposure to the virus and do their part to preserve healthcare resources for those afflicted with COVID-19. In places that have relaxed stay-at-home orders, people are starting to head back to the clinic to get the care they need.

Read more. . .

Dr. Henry Miller and John Batchelor Review FDA COVID-19 Guidelines
The John Batchelor Show | Henry Miller, M.S., M.D.
July 1, 2020

PRI’s Dr. Henry Miller joins the John Batchelor Show to review the latest developments with the vaccine guidelines and the FDA. The FDA recently testified before Congress that they will have complicated guidelines for a potential COVID-19 vaccine. Miller mentioned that the FDA guidelines are reassuring as it indicates that future vaccines will be vetted like any other vaccine evaluation (pre-critical data, manufacturing and controls, and clinical data).

Listen here. . .

Coronavirus drug cost – Ignore critics. Here’s why the price is right
Fox News | Sally C. Pipes
July 5, 2020

Given the drug’s benefits, and the potential savings for the health care system, Gilead’s proposed $3,100 price is eminently fair. The Institute for Clinical and Economic Review – a group that sets cost-effectiveness thresholds for new drugs and is generally critical of the pharmaceutical industry – admitted that Gilead “made a responsible pricing decision.” ICER concluded that Gilead could reasonably charge up to $5,080 for a 10-day course of remdesivir.

Read more. . .